The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the Danish drugmaker is passing over its U.S. rights to its partner. Effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback